Brief: Amylyx Pharmaceuticals Announces Pricing Of $175 Million Underwritten Public Offering Of Common Stock
10/09/2025 05:08
Sept 10 (Reuters) - Amylyx Pharmaceuticals Inc AMLX.O: AMYLYX PHARMACEUTICALS ANNOUNCES PRICING OF $175 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK AMYLYX PHARMACEUTICALS INC - PRICES 17.5 MILLION SHARES AT $10 EACH Source text: ID:nBw9HS9GHa Further company coverage: AMLX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amylyx Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-LSI Industries, SiTime, Andersen Group
U.S. STOCKS ON THE MOVE-Apple, Hims & Hers Health, Sysco
U.S. STOCKS ON THE MOVE-Nordson, Nebius, Deere
Amylyx dips after increased $500 mln stock sale to fund blood sugar drug
Brief: Amylyx Pharmaceuticals Announces Pricing Of Upsized $500 Million Underwritten Public Offering Of Common Stock